Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$712M |
| 2 |
PepsiCo
PEP
|
+$669M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$635M |
| 4 |
Walmart Inc
WMT
|
+$544M |
| 5 |
Palantir
PLTR
|
+$538M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.34B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.65B |
| 3 |
Tesla
TSLA
|
+$1.45B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.01B |
| 5 |
Apple
AAPL
|
+$833M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Financials | 7.27% |
| 3 | Consumer Discretionary | 6.82% |
| 4 | Communication Services | 5.06% |
| 5 | Healthcare | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
The Bancorp
TBBK
$3B
| $5.38M | ﹤0.01% |
71,884
-44,865
| -38% | -$3.13M |
|
|
ARES.PRB
2127
Ares Management Corp 6.75% Series B Preferred Stock
ARES.PRB
$1.34B
| $5.37M | ﹤0.01% |
108,157
+100,758
| +1,362% | +$5.58M |
|
2128
Atmus Filtration Technologies
ATMU
$4.5B
| $5.37M | ﹤0.01% |
119,044
-45,366
| -28% | -$1.9M |
|
2129
Ligand Pharmaceuticals
LGND
$6.03B
| $5.36M | ﹤0.01% |
30,283
-8,698
| -22% | -$1.29M |
|
2130
Korn Ferry
KFY
$4.23B
| $5.36M | ﹤0.01% |
76,606
-32,601
| -30% | -$2.38M |
|
2131
Syndax Pharmaceuticals
SNDX
$1.69B
| $5.35M | ﹤0.01% |
348,061
-34,905
| -9% | -$457K |
|
2132
Flowers Foods
FLO
$1.55B
| $5.35M | ﹤0.01% |
409,771
-11,852
| -3% | -$180K |
|
2133
CALL
Sarepta Therapeutics
SRPT
$1.73B
| $5.34M | ﹤0.01% |
277,300
+165,000
| +147% | +$2.94M |
|
2134
Argan
AGX
$8.66B
| $5.34M | ﹤0.01% |
19,776
-19,391
| -50% | -$4.44M |
|
2135
First Bancorp
FBP
$4.46B
| $5.33M | ﹤0.01% |
241,900
-139,823
| -37% | -$3.02M |
|
2136
PUT
Zoom
ZM
$29.9B
| $5.33M | ﹤0.01% |
64,600
+14,600
| +29% | +$1.14M |
|
2137
National Health Investors
NHI
$3.61B
| $5.32M | ﹤0.01% |
66,936
-22,405
| -25% | -$1.68M |
|
2138
PUT
Riot Platforms
RIOT
$8.15B
| $5.32M | ﹤0.01% |
279,400
+239,400
| +599% | +$3.32M |
|
2139
Banco Bradesco
BBD
$37.9B
| $5.3M | ﹤0.01% |
1,568,232
-32,535
| -2% | -$98.2K |
|
2140
DNOW Inc
DNOW
$2.63B
| $5.3M | ﹤0.01% |
347,507
-147,710
| -30% | -$2.23M |
|
2141
Frontline
FRO
$8.68B
| $5.28M | ﹤0.01% |
231,532
-47,636
| -17% | -$965K |
|
|
WRD
2142
WeRide Inc
WRD
$1.97B
| $5.28M | ﹤0.01% |
532,982
-11,441
| -2% | -$108K |
|
2143
PUT
NRG Energy
NRG
$24.7B
| $5.26M | ﹤0.01% |
+32,500
| New | +$5.06M |
|
2144
CALL
Affirm
AFRM
$26.2B
| $5.26M | ﹤0.01% |
72,000
-100,200
| -58% | -$7.63M |
|
2145
Griffon
GFF
$4.29B
| $5.26M | ﹤0.01% |
69,031
-206,255
| -75% | -$15.9M |
|
2146
Aurora
AUR
$14.2B
| $5.24M | ﹤0.01% |
972,147
+268,193
| +38% | +$1.57M |
|
2147
IES Holdings
IESC
$15.1B
| $5.24M | ﹤0.01% |
13,177
-5,958
| -31% | -$2.05M |
|
2148
PUT
HubSpot
HUBS
$12.7B
| $5.24M | ﹤0.01% |
+11,200
| New | +$5.63M |
|
2149
PUT
MP Materials
MP
$8.45B
| $5.23M | ﹤0.01% |
+78,000
| New | +$4.91M |
|
2150
WesBanco
WSBC
$4.06B
| $5.22M | ﹤0.01% |
163,566
-189,133
| -54% | -$6.03M |
|
Similar funds
Barclays's Q3 2025 Portfolio in Review
As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
- Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
- Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
- Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
- Barclays opened 615 new positions and closed 340 in Q3 2025.
- Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.
Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.